Move at the Speed of Experience™ 

Extensive Real-World Expertise and Proficiency

Collectively, RCP brings more than 125 years in rare disease and 30 years in gene therapy of combined global commercialization experience having created new markets and launched 16 products across 17 therapeutic areas.

Our Private Markets practice is uniquely positioned to service our Private Equity and Venture Capital owned clients. Optimized commercial readiness is a path to quickly unlock an organizations potential, drive Time to Value and ultimately have a positive impact to EBITDA.

Our value comes from the depth and breadth of real-world experience.

Select Areas of Expertise

Asset Valuation Market and Patient Access Strategy Key Investigator/ Opinion Leader Development Value Creation Proposition Market Analysis and Brand Plan Commercial Launch Readiness and Execution Entrance into US Market Medical Affairs Commercial Operations Acquisition Diligence Unbiased Commercial Viability Patient Identification Field Optimization Qualified Treatment Center Selection Real-World Patient Data Patient Advocacy Pricing and Reimbursement Market Sizing and Analytics

Value Creation Opportunities

Commercial Fundamentals

  • Commercial strategy and marketing
  • Market assessment and positioning
  • Shared medical services
  • Investor story/slide deck
  • Investigator/ Key Opinion Leader (KOL) identification and development
  • Patient identification and diagnostics
  • Patient journey
  • Diagnostic landscape analysis
  • Disease awareness and branded campaigns
  • Advisory boards, roundtable meetings and symposia
  • Team development/optimization

Medical Device Commercialization

How RCP can Help Bring Clarity to Your MedTech Venture

  1. Uncover the Hidden Barriers to successful commercialization of new medical device technologies
  2. Develop True Product Viability and Market Value with market feedback, product positioning, and pricing strategies
  3. Establish a market presence through clinical evidence, regulatory and reimbursement guidance, and development of appropriate distribution channels
Medical Device Commercialization Honeycomb